Los Angeles Biotechnology Network
  • Home
  • About
  • News
    • All LABN News
    • Trending LABN News
  • Jobs
    • All LABN Jobs
    • Post A Job
  • Subscribe
  • Contact
News Ticker
  • [ October 2, 2022 ] Biomechanics consultant – Semper Scientific – Mission Viejo, CA Los Angeles Biotech Jobs
  • [ October 1, 2022 ] Product Quality Lead – CAPRICOR THERAPEUTICS, INC – Los Angeles, CA Los Angeles Biotech Jobs
  • [ October 1, 2022 ] Sr. Biomanufacturing Manager, Upstream & Downstream (Cell & Gene Therapy) – Avid Bioservices – Tustin, CA Los Angeles Biotech Jobs
  • [ October 1, 2022 ] Scientist, Analytical Development – Atara Biotherapeutics, Inc. – Thousand Oaks, CA Los Angeles Biotech Jobs
  • [ October 1, 2022 ] GMP Project Engineer/Sr. Engineer, Capital Projects – Avid Bioservices – Tustin, CA Los Angeles Biotech Jobs
HomeLos Angeles Biotech NewsDermavant Reports Positive Phase 3 Results for Tapinarof Cream in Adult Patients with Plaque Psoriasis

Dermavant Reports Positive Phase 3 Results for Tapinarof Cream in Adult Patients with Plaque Psoriasis

August 26, 2020 Los Angeles Biotechnology Network News Los Angeles Biotech News Comments Off on Dermavant Reports Positive Phase 3 Results for Tapinarof Cream in Adult Patients with Plaque Psoriasis
LONG BEACH, Calif. & BASEL, Switzerland--(BUSINESS WIRE)--Dermavant Reports Positive Phase 3 Results for Tapinarof Cream in Adult Patients with Plaque Psoriasis

Click to view original post

Previous

ChromaDex to Present at the LD 500 Virtual Investor Conference

Next

A Forbion-funded startup bought the rights to Amgen’s CETP inhibitor, and is giving the cholesterol drug another go

Follow/Subscribe

POST A JOB
Tweets by LABioNetwork

Copyright © 2021 Biotech Networks, LLC

Want to Save Time?

Get Trending News & Jobs Delivered